The Deal Register
Database › Equity financing › EARLY WARNING NEWS RELEASE ISSUED PURSUANT TO THE NATIONAL INSTRUMENT…

Equity financing

EARLY WARNING NEWS RELEASE ISSUED PURSUANT TO THE NATIONAL INSTRUMENT 62-103

Lane
Equity financing
Announced
06 Jan 2026
Province
Quebec
Industry
Unclassified
Status
Announced
What the filing says
This news release is related to the offering of unsecured convertible debentures (each, a " Debenture " and, collectively, the " Debentures ") of Groupe LSL Pharma inc., LSL Pharma Group Inc. (the " Issuer ").
Terms stated
conversion price, price per security
Source

The terms are in the subscriber edition

This transaction carries 2 stated terms, with the value, unit and basis of each and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe